Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity

El Euch IZ, Frese M, Sewald N, Smaoui S, Shaaban M, Mellouli L (2018)
MEDICINAL CHEMISTRY RESEARCH 27(4): 1085-1092.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ;
Abstract / Bemerkung
An actinomycete strain designated TN82 was isolated from Tunisian Sahara soil and selected for its interesting antimicrobial activity against Gram positive and Gram negative bacteria and fungi. Based on the results of cultural characteristic, the 16S rRNA gene nucleotide sequence (1434 bp, accession nA degrees LT608133) and the phylogenetic analysis, this new isolate was assigned as Streptomyces sp. TN82 strain. Two active compounds, 3-phenylpyrazin-2(1H)-one (1) and 3-O-methylviridicatin (2), described for the first time as natural product and bacterial compound respectively, together with four known bacterial metabolites; cyclo-(Leu, Pro) (3), anthranilic acid (4), indole-3-carbaldehyde (5) and p-hydroxybenzoic acid (6) were isolated from the culture broth of this strain. Structure of the natural compound (1) was confirmed by extensive 1D and 2D NMR and EI MS and ESI HR mass measurements, and by comparison with literature data. Minimum inhibitory concentrations of the two compounds (1) and (2) against the tested human pathogenic bacteria S. aureus, L. monocytogenes and S. typhimurium were significantly lower than those of kanamycin. For the natural compound 3-phenylpyrazin-2(1H)-one (1), MICs values were very interesting especially that against L. monocytogenes (1.0 mu g/mL) which is 2 and 12 times lower than those of ampicillin (2.0 mu g/mL) and kanamycin (12.50 mu g/mL), respectively.
Erscheinungsjahr
Zeitschriftentitel
MEDICINAL CHEMISTRY RESEARCH
Band
27
Zeitschriftennummer
4
Seite
1085-1092
ISSN
eISSN
PUB-ID

Zitieren

El Euch IZ, Frese M, Sewald N, Smaoui S, Shaaban M, Mellouli L. Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity. MEDICINAL CHEMISTRY RESEARCH. 2018;27(4):1085-1092.
El Euch, I. Z., Frese, M., Sewald, N., Smaoui, S., Shaaban, M., & Mellouli, L. (2018). Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity. MEDICINAL CHEMISTRY RESEARCH, 27(4), 1085-1092. doi:10.1007/s00044-017-2130-4
El Euch, I. Z., Frese, M., Sewald, N., Smaoui, S., Shaaban, M., and Mellouli, L. (2018). Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity. MEDICINAL CHEMISTRY RESEARCH 27, 1085-1092.
El Euch, I.Z., et al., 2018. Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity. MEDICINAL CHEMISTRY RESEARCH, 27(4), p 1085-1092.
I.Z. El Euch, et al., “Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity”, MEDICINAL CHEMISTRY RESEARCH, vol. 27, 2018, pp. 1085-1092.
El Euch, I.Z., Frese, M., Sewald, N., Smaoui, S., Shaaban, M., Mellouli, L.: Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity. MEDICINAL CHEMISTRY RESEARCH. 27, 1085-1092 (2018).
El Euch, Imene Zendah, Frese, Marcel, Sewald, Norbert, Smaoui, Slim, Shaaban, Mohamed, and Mellouli, Lotfi. “Bioactive secondary metabolites from new terrestrial Streptomyces sp TN82 strain: Isolation, structure elucidation and biological activity”. MEDICINAL CHEMISTRY RESEARCH 27.4 (2018): 1085-1092.